A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ling,Li

第一单位： Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.

作者： Ling,Li ^[1] ; Bao-Jia,Zou ^[2] ; Juan-Zhi,Zhao ^[1] ; Jia-Bi,Liang ^[1] ; Zi-Yue,She ^[1] ; Wen-Ying,Zhou ^[3] ; Si-Xiao,Lin ^[3] ; Lin,Tian ^[1] ; Wen-Ji,Luo ^[1] ; Fa-Zhong,He ^[4]

作者单位： Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China. ^[1] Department of Hepatobiliary Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. ^[2] Department of Central Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China. ^[3] Department of Quality Control, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, Guangdong, China. ^[4]

关键词 DNA damage repair-based prognostic signature NSCLC classification biomarker non-small lung cancer (NSCLC)tumor microenvironment

DOI 10.3389/fonc.2022.961274

PMID 36408135

发布时间 2022-11-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

961274页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除